Impaired Levodopa Response in Parkinsonʼs Disease During Melanoma Therapy
- 1 February 1992
- journal article
- case report
- Published by Wolters Kluwer Health in Clinical Neuropharmacology
- Vol. 15 (1) , 69-74
- https://doi.org/10.1097/00002826-199202000-00010
Abstract
A patient with melanoma and sporadic positive melanuria developed Parkinson's disease. Treatment with levodopa failed to modify tumoral progress. However, during chemotherapy with dacarbazine, the patient experienced a significant impairment to levodopa response.Keywords
This publication has 0 references indexed in Scilit: